Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
X4 Pharmaceuticals, Inc has filed 808 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 801-808 of 808 matching filings.

Per page
25
Current page
33
D File 021-286233

D filing

Filing date
08 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-262117

D filing

Filing date
27 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-254201

D filing

Filing date
30 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D/A File 021-201235

D/A filing

Filing date
05 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D/A File 021-201235

D/A filing

Filing date
11 Aug 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-201235

D filing

Filing date
13 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-154945

D filing

Filing date
07 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-148139

D filing

Filing date
24 Sep 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .